Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1928
Source ID: NCT00111631
Associated Drug: Dpp-Iv Inhibitor
Title: A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus Type 2
Interventions: DRUG: DPP-IV Inhibitor|DRUG: Metformin|DRUG: Placebo
Outcome Measures: Primary: Absolute change from baseline in HbAlc\n, Week 16 | Secondary: Absolute change in FPG and absolute/relative change in insulin sensitivity, beta-cell-function, and lipid profile, response rate\n, Week 16|AEs, vital signs, laboratory tests, body weight, waist/hip ratio, ECG\n, Throughout study
Sponsor/Collaborators: Sponsor: Hoffmann-La Roche
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 218
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2005-05
Completion Date: 2006-10
Results First Posted:
Last Update Posted: 2016-11-02
Locations: Concord, California, 94520, United States|Salinas, California, 93901, United States|San Diego, California, 92161, United States|Boulder, Colorado, 80304, United States|Newark, Delaware, 19713, United States|Wilmington, Delaware, 19085, United States|Clearwater, Florida, 33765, United States|Miami, Florida, 33156, United States|Chicago, Illinois, 60607, United States|Detroit, Michigan, 48202-2689, United States|Buffalo, New York, 14209, United States|Rochester, New York, 14609, United States|Durham, North Carolina, 27713, United States|Mogadore, Ohio, 44260, United States|Portland, Oregon, 97239, United States|Connellsville, Pennsylvania, 15425, United States|Warminster, Pennsylvania, 18974, United States|Dallas, Texas, 75246, United States|Midland, Texas, 79707, United States|San Antonio, Texas, 78229, United States|Adelaide, 5000, Australia|Sydney, 2050, Australia|Winnipeg, Manitoba, R3E 3P4, Canada|Halifax, Nova Scotia, B3H 1V7, Canada|London, Ontario, NGA 4V2, Canada|Toronto, Ontario, M5C 2T2, Canada|Bad Lauterberg, 37431, Germany|Berlin, 10115, Germany|Dresden, 01307, Germany|Görlitz, 02826, Germany|Mainz, 55116, Germany|Neuss, 41460, Germany|Ancona, 60131, Italy|Firenze, 50100, Italy|Napoli, 80100, Italy|Udine, 33100, Italy|Ponce, 00716, Puerto Rico
URL: https://clinicaltrials.gov/show/NCT00111631

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D445 Dapagliflozin small molecule DB06292 Details
D089 Metformin small molecule DB00331 Details